1. Home
  2. ZLAB vs FRSH Comparison

ZLAB vs FRSH Comparison

Compare ZLAB & FRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • FRSH
  • Stock Information
  • Founded
  • ZLAB 2013
  • FRSH 2010
  • Country
  • ZLAB China
  • FRSH United States
  • Employees
  • ZLAB N/A
  • FRSH N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • FRSH EDP Services
  • Sector
  • ZLAB Health Care
  • FRSH Technology
  • Exchange
  • ZLAB Nasdaq
  • FRSH Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • FRSH 3.9B
  • IPO Year
  • ZLAB 2017
  • FRSH 2021
  • Fundamental
  • Price
  • ZLAB $30.14
  • FRSH $15.27
  • Analyst Decision
  • ZLAB Buy
  • FRSH Buy
  • Analyst Count
  • ZLAB 4
  • FRSH 14
  • Target Price
  • ZLAB $47.37
  • FRSH $20.00
  • AVG Volume (30 Days)
  • ZLAB 944.8K
  • FRSH 2.6M
  • Earning Date
  • ZLAB 05-08-2025
  • FRSH 07-29-2025
  • Dividend Yield
  • ZLAB N/A
  • FRSH N/A
  • EPS Growth
  • ZLAB N/A
  • FRSH N/A
  • EPS
  • ZLAB N/A
  • FRSH N/A
  • Revenue
  • ZLAB $418,326,000.00
  • FRSH $751,550,000.00
  • Revenue This Year
  • ZLAB $44.07
  • FRSH $15.97
  • Revenue Next Year
  • ZLAB $49.13
  • FRSH $12.28
  • P/E Ratio
  • ZLAB N/A
  • FRSH N/A
  • Revenue Growth
  • ZLAB 43.72
  • FRSH 20.46
  • 52 Week Low
  • ZLAB $16.01
  • FRSH $10.81
  • 52 Week High
  • ZLAB $39.77
  • FRSH $19.77
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 46.27
  • FRSH 57.54
  • Support Level
  • ZLAB $30.11
  • FRSH $14.73
  • Resistance Level
  • ZLAB $31.34
  • FRSH $16.14
  • Average True Range (ATR)
  • ZLAB 1.09
  • FRSH 0.41
  • MACD
  • ZLAB 0.07
  • FRSH -0.02
  • Stochastic Oscillator
  • ZLAB 43.07
  • FRSH 54.21

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About FRSH Freshworks Inc.

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.

Share on Social Networks: